Potential bias of instrumental variable analyses for observational comparative effectiveness research

Annals of Internal Medicine

Volumn 161, Issue 2, 2014, Pages 131-138

  Garabedian, Laura Faden ^a   Chu, Paula ^a,b   Toh, Sengwee ^a   Zaslavsky, Alan M ^a   Soumerai, Stephen B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE EFFECTIVENESS; HEALTH STATUS; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PHYSICIAN; PRIORITY JOURNAL; RACE; RISK FACTOR; RURAL AREA; SOCIAL STATUS; SYSTEMATIC REVIEW; URBAN AREA;

BIAS (EPIDEMIOLOGY); COMPARATIVE EFFECTIVENESS RESEARCH; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; OBSERVATIONAL STUDY AS TOPIC; REGRESSION ANALYSIS;

EID: 84904398849     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-1887     Document Type: Article

References (67)

1. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: Institute of Medicine; 2009. Accessed at www.iom.edu/Reports/2009/ComparativeEffectivenessResearchPriorities.aspx on 31 January 2011.
2. Tunis SR, Benner J, McClellan M. Comparative effectiveness research: Policy context, methods development and research infrastructure. Stat Med. 2010;29: 1963-76. [PMID: 20564311]
3. Garber AM. How the Patient-Centered Outcomes Research Institute can best influence real-world health care decision making. Health Aff (Millwood). 2011; 30:2243-51. [PMID: 22147851]
4. Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-experimental Designs for Generalized Causal Inference. Boston: Houghton Mifflin; 2002:33-63.
5. Brookhart MA, Rassen JA, Schneeweiss S. Instrumental variable methods in comparative safety and effectiveness research. Pharmacoepidemiol Drug Saf. 2010;19:537-54. [PMID: 20354968]
6. Johnson ML, Crown W, Martin BC, Dormuth CR, Siebert U. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part III. Value Health. 2009;12:1062-73. [PMID: 19793071]
7. Patient-Centered Outcomes Research Institute. PCORI Methodology Standards. Washington, DC: Patient-Centered Outcomes Research Institute; 2013. Accessed at www.pcori.org/assets/PCORI-Methodology-Standards.pdf on 14 February 2013.
8. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272:859-66. [PMID: 8078163] (Pubitemid 24282095)
9. McClellan M. Are the returns to technological change in health care declining? Proc Natl Acad Sci U S A. 1996;93:12701-8. [PMID: 8917482]
10. Brooks JM, McClellan M, Wong HS. The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter? Inquiry. 2000;37:75-90. [PMID: 10892359] (Pubitemid 30415716)
11. Glickman ME, Normand ST. The derivation of a latent threshold instrumental variables model. Stat Sin. 2000;10:517-44.
12. Beck CA, Penrod J, Gyorkos TW, Shapiro S, Pilote L. Does aggressive care following acute myocardial infarction reduce mortality? Analysis with instrumental variables to compare effectiveness in Canadian and United States patient populations. Health Serv Res. 2003;38:1423-40. [PMID: 14727781] (Pubitemid 38063932)
13. Cutler DM. The lifetime costs and benefits of medical technology. J Health Econ. 2007;26:1081-100. [PMID: 18023900] (Pubitemid 350166638)
14. Pilote L, Beck CA, Eisenberg MJ, Humphries K, Joseph L, Penrod JR, et al. Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases. Am Heart J. 2008;155:42-8. [PMID: 18082487] (Pubitemid 350234788)
15. Little RJ, Rubin DB. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annu Rev Public Health. 2000;21:121-45. [PMID: 10884949] (Pubitemid 30480319)
16. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91:444-55. (Pubitemid 126412813)
17. Landrum MB, Ayanian JZ. Causal effect of ambulatory specialty care on mortality following myocardial infarction: a comparison of propensity score and instrumental variable analyses. Health Serv Outcomes Res Methodol. 2001;2: 221-45.
18. Angrist JD, Pischke JS. Mostly Harmless Econometrics: An Empiricist's Companion. Princeton: Princeton Univ Pr; 2009.
19. Wooldridge JM. Introductory Econometrics: A Modern Approach. 3rd ed. Mason, OH: Thomson; 2006.
20. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health. 1998;19:17-34. [PMID: 9611610] (Pubitemid 28279922)
21. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722-9. [PMID: 10922351] (Pubitemid 30612241)
22. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology. 2006;17: 260-7. [PMID: 16617274]
23. Glymour MM. Natural experiments and instrumental variable analyses in social epidemiology. In: Oakes JM, Kaufman JS, eds. Methods in Social Epidemiology. San Francisco: J Wiley; 2006:429-68.
24. Hernán MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006;17:360-72. [PMID: 16755261] (Pubitemid 44305508)
25. Grootendorst P. A review of instrumental variables estimation of treatment effects in the applied health sciences. Health Serv Outcomes Res Methodol. 2007;10:159-79. (Pubitemid 350064633)
26. Rosenbaum PR. Design of Observational Studies. New York: Springer; 2010:139-40.
27. Chen Y, Briesacher BA. Use of instrumental variable in prescription drug research with observational data: a systematic review. J Clin Epidemiol. 2011;64: 687-700. [PMID: 21163621]
28. Davies NM, Smith GD, Windmeijer F, Martin RM. Issues in the reporting and conduct of instrumental variable studies: a systematic review. Epidemiology. 2013;24:363-9. [PMID: 23532055]
29. Swanson SA, Hernán MA. Commentary: how to report instrumental variable analyses (suggestions welcome). Epidemiology. 2013;24:370-4. [PMID: 23549180]
30. Murray CJ, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, Iandiorio TJ, et al. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med. 2006;3:e260. [PMID: 16968116]
31. Cosby AG, Neaves TT, Cossman RE, Cossman JS, James WL, Feierabend N, et al. Preliminary evidence for an emerging nonmetropolitan mortality penalty in the United States. Am J Public Health. 2008;98:1470-2. [PMID: 18556611]
32. Cossman JS, James WL, Cosby AG, Cossman RE. Underlying causes of the emerging nonmetropolitan mortality penalty. Am J Public Health. 2010;100: 1417-9. [PMID: 20558803]
33. Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16:309-30. [PMID: 17715159] (Pubitemid 47215256)
34. Hu Y, Schennach SM. Instrumental variable treatment of nonclassical measurement error models. Econometrica. 2008;76:195-216.
35. Abrams TE, Vaughan-Sarrazin M, Fan VS, Kaboli PJ. Geographic isolation and the risk for chronic obstructive pulmonary disease-related mortality: a cohort study. Ann Intern Med. 2011;155:80-6. [PMID: 21768581]
36. Khan JA, Casper M, Asimos AW, Clarkson L, Enright D, Fehrs LJ, et al. Geographic and sociodemographic disparities in drive times to Joint Commission-certified primary stroke centers in North Carolina, South Carolina, and Georgia. Prev Chronic Dis. 2011;8:A79. [PMID: 21672403]
37. Lorch SA, Silber JH, Even-Shoshan O, Millman A. Use of prolonged travel to improve pediatric risk-adjustment models. Health Serv Res. 2009;44:519-41. [PMID: 19207591]
38. Ambardekar AV, Fonarow GC, Dai D, Peterson ED, Hernandez AF, Cannon CP, et al Get With The Guidelines Steering Committee and Hospitals. Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program). Am J Cardiol. 2010;105:139-43. [PMID: 20102907]
39. Vukmir RB. Survival from prehospital cardiac arrest is critically dependent upon response time. Resuscitation. 2006;69:229-34. [PMID: 16500015]
40. Maybury RS, Chang DC, Freischlag JA. Rural hospitals face a higher burden of ruptured abdominal aortic aneurysm and are more likely to transfer patients for emergent repair. J Am Coll Surg. 2011;212:1061-7. [PMID: 21458304]
41. Hutt E, Elder SJ, Fish R, Min SJ. Regional variation in mortality and subsequent hospitalization of nursing residents with heart failure. J Am Med Dir Assoc. 2011;12:595-601. [PMID: 21450206]
42. Welch HG, Sharp SM, Gottlieb DJ, Skinner JS, Wennberg JE. Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries. JAMA. 2011;305:1113-8. [PMID: 21406648]
43. Fisher ES, Wennberg JE, Stukel TA, Skinner JS, Sharp SM, Freeman JL, et al. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. Health Serv Res. 2000;34:1351-62. [PMID: 10654835] (Pubitemid 30075414)
44. Chen J, Krumholz HM, Wang Y, Curtis JP, Rathore SS, Ross JS, et al. Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med. 2010;170:433-9. [PMID: 20212179]
45. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Geographic variation in implantable cardioverter-defibrillator use and heart failure survival. Med Care. 2012;50:10-7. [PMID: 22167063]
46. Galandiuk S, Mahid SS, Polk HC Jr, Turina M, Rao M, Lewis JN. Differences and similarities between rural and urban operations. Surgery. 2006;140: 589-96. [PMID: 17011906] (Pubitemid 44442345)
47. Ayanian JZ, Weissman JS. Teaching hospitals and quality of care: a review of the literature. Milbank Q. 2002;80:569-93, v. [PMID: 12233250]
48. Hayanga AJ, Mukherjee D, Chang D, Kaiser H, Lee T, Gearhart S, et al. Teaching hospital status and operative mortality in the United States: tipping point in the volume-outcome relationship following colon resections? Arch Surg. 2010;145:346-50. [PMID: 20404284]
49. Billingsley KG, Morris AM, Dominitz JA, Matthews B, Dobie S, Barlow W, et al. Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg. 2007;142:23-31. [PMID: 17224497]
50. Willison DJ, Soumerai SB, Palmer RH. Association of physician and hospital volume with use of aspirin and reperfusion therapy in acute myocardial infarction. Med Care. 2000;38:1092-102. [PMID: 11078050]
51. Southern WN, Bellin EY, Arnsten JH. Longer lengths of stay and higher risk of mortality among inpatients of physicians with more years in practice. Am J Med. 2011;124:868-74. [PMID: 21745651]
52. Weissman J, Meyers BS, Ghosh S, Bruce ML. Sociodemographic and clinical factors associated with antidepressant type in a national sample of the home health care elderly. Gen Hosp Psychiatry. 2011;33:587-93. [PMID: 21920609]
53. Groenwold RH, Hak E, Klungel OH, Hoes AW. Instrumental variables in influenza vaccination studies: mission impossible?!. Value Health. 2010;13:132-7. [PMID: 19695007]
54. Brookhart MA, Rassen JA, Wang PS, Dormuth C, Mogun H, Schneeweiss S. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care. 2007;45:S116-22. [PMID: 17909369]
55. Parsons C, Johnston S, Mathie E, Baron N, Machen I, Amador S, et al. Potentially inappropriate prescribing in older people with dementia in care homes: a retrospective analysis. Drugs Aging. 2012;29:143-55. [PMID: 22204669]
56. Shahinian VB, Kuo YF, Gilbert SM. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med. 2010;363:1822-32. [PMID: 21047226]
57. Fischer MA, Choudhry NK, Winkelmayer WC. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing? Health Aff (Millwood). 2007;26:800-7. [PMID: 17485759]
58. Tsai AC, Votruba M, Bridges JF, Cebul RD. Overcoming bias in estimating the volume-outcome relationship. Health Serv Res. 2006;41:252-64. [PMID: 16430610]
59. Sundmacher L, Busse R. The impact of physician supply on avoidable cancer deaths in Germany. A spatial analysis. Health Policy. 2011;103:53-62. [PMID: 21962525]
60. Weiner BJ, Alexander JA, Shortell SM, Baker LC, Becker M, Geppert JJ. Quality improvement implementation and hospital performance on quality indicators. Health Serv Res. 2006;41:307-34. [PMID: 16584451] (Pubitemid 43374274)
61. Gillum LA, Johnston SC. Influence of physician specialty on outcomes after acute ischemic stroke. J Hosp Med. 2008;3:184-92. [PMID: 18570345]
62. Zaslavsky AM, Ayanian JZ, Zaborski LB. The validity of race and ethnicity in enrollment data for Medicare beneficiaries. Health Serv Res. 2012;47:1300-21. [PMID: 22515953]
63. Carroll CJ, Ruppert D, Stefanski LA, Crainiceanu C. Measurement Error in Nonlinear Models: A Modern Perspective. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC; 2006.
64. Geronimus AT, Bound J, Colen CG. Excess black mortality in the United States and in selected black and white high-poverty areas, 1980-2000. Am J Public Health. 2011;101:720-9. [PMID: 21389293]
65. Brookhart MA, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat. 2007;3:Article 14. [PMID: 19655038]
66. Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, et al Oregon Health Study Group. The Oregon experiment-effects of Medicaid on clinical outcomes. N Engl J Med. 2013;368:1713-22. [PMID: 23635051]
67. Angrist JD, Krueger AB. Instrumental variables and the search for identification: From supply and demand to natural experiments. J Econ Perspect. 2001;15:69-85. (Pubitemid 33594775)